Charles:
You are right, there are large violations. I'm confused about the values that 
should be used in the CS and DC tables.
Our experimental collaborators have given us a table of the CS values (let's 
call it Set 1), but another computational collaborator uses the value that is 
subtracted by the isotropic value, 119.3 ppm for non-Glycine residues (let's 
call this Set 2. In this table, each value is the corresponding value from Set 
1 minus 119.3).
It seems strange for me that when Set 1 was used, the structures look OK, but 
with huge violations for CS;  when Set 2 was used, the structure look strange 
but violations are small. What do you think might be the problem? Do the 
simulation parameters in refine.py matter much? Is there a script specifically 
designed for membrane proteins?
Thanks a lot.
Jian

________________________________________
From: Charles Schwieters [[email protected]]
Sent: Monday, June 25, 2012 11:56 AM
To: DAI, JIAN
Cc: xplor-nih at nmr.cit.nih.gov
Subject: Re: [Xplor-nih] Factors that determine the tilt angle of a peptide

Hello Jian--

> We are calculating the structure of a membrane peptide with two
> helices linked with a loop with PISEMA data (chemical shift, dipolar
> coupling) with dihedral angle? hydrogen bond restraints for the
> helical part, we also have some distance restraints for atoms from
> both helices.
>
> From PISEMA experiment we expect to get models with the right tilt
> angle with respect to the membrane normal (i.e., the z-axis), but we
> got models with a variety of tilt angles. For example, we expect to
> have a tilt angle of 12 to 17 degrees, but some of the models have
> tilt angle that is 26, which is way too large.
> I'm wondering what are the factors that determine the tilt angle of
> the peptide in XPLOR calculation.

Are your restraints well-satisfied? There may be some problem such
that there are large violations causing convergence problems. If your
PISEMA-based restraints are satisfied, then the tilt angle should be
correct. No?

best regards--
Charles



Reply via email to